Literature DB >> 32016016

Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy.

Luis Miguel Juárez-Salcedo1, Samir Dalia2.   

Abstract

Year:  2019        PMID: 32016016      PMCID: PMC6976474          DOI: 10.21037/atm.2019.11.11

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  11 in total

1.  Cellular and humoral immune response in progressive multifocal leukoencephalopathy.

Authors:  F Weber; C Goldmann; M Krämer; F J Kaup; M Pickhardt; P Young; H Petry; T Weber; W Lüke
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

2.  Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.

Authors:  Irene Cortese; Pawel Muranski; Yoshimi Enose-Akahata; Seung-Kwon Ha; Bryan Smith; MariaChiara Monaco; Caroline Ryschkewitsch; Eugene O Major; Joan Ohayon; Matthew K Schindler; Erin Beck; Lauren B Reoma; Steve Jacobson; Daniel S Reich; Avindra Nath
Journal:  N Engl J Med       Date:  2019-04-10       Impact factor: 91.245

3.  Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.

Authors:  Susama Verma; Katia Cikurel; Igor J Koralnik; Susan Morgello; Charlotte Cunningham-Rundles; Zelig R Weinstein; Christine Bergmann; David M Simpson
Journal:  J Infect Dis       Date:  2007-07-13       Impact factor: 5.226

Review 4.  Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS.

Authors:  P N Jensen; E O Major
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

5.  Progressive multifocal leukoencephalopathy.

Authors:  B R Brooks; D L Walker
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

6.  Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals.

Authors:  R Caldarelli-Stefano; L Vago; E Omodeo-Zorini; M Mediati; L Losciale; M Nebuloni; G Costanzi; P Ferrante
Journal:  J Neurovirol       Date:  1999-04       Impact factor: 2.643

7.  Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.

Authors:  Chen Sabrina Tan; Evelyn Bord; Thomas A Broge; Brett Glotzbecker; Heidi Mills; Sarah Gheuens; Jacalyn Rosenblatt; David Avigan; Igor J Koralnik
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

8.  Progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome.

Authors:  C Bernick; J B Gregorios
Journal:  Arch Neurol       Date:  1984-07

9.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 10.  Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.

Authors:  Chandrashekar Bohra; Lubomir Sokol; Samir Dalia
Journal:  Cancer Control       Date:  2017 Oct-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.